Toetal Solutions is a foot and ankle medical device company focused on creating easy-to-use clinical solutions for rigid hammertoe deformities. Its flagship product, the Ziptoe Hammertoe System, features a proprietary deployable nitinol implant that comes sterile packed with disposable instrumentation and is designed to provide immediate stable fusion. The system was developed with surgeon input and can address the MTPJ when necessary to treat the total pathology. The company positions the implant as easy to use in any surgical setting and aims to improve patient outcomes while simplifying surgeons' workflow. Toetal closed $1.8 million in additional financing from Runway Healthcare, LP with participation from Runway Healthcare investors to finalize product development and pursue regulatory clearance. Runway Healthcare also manages product development for its portfolio companies and plans to seek transition of Toetal's ownership to a larger multinational healthcare company for commercialization. Toetal Solutions, founded in 2021 and based in Philadelphia, develops easy-to-use medical devices for foot and ankle deformities. Its flagship product, the Ziptoe™ Hammertoe System, is a sterile-packed deployable nitinol implant supplied with disposable instrumentation to treat rigid hammertoe deformities in any surgical setting. The Ziptoe system is designed to provide Active Compression, Complete Stability, and Zero Rotation to promote bone fusion and allows for easy revision if necessary. Toetal says it has designed the product with physician input throughout development. The company announced it closed $1.02M in an initial financing to accelerate development of the Ziptoe system. Runway Healthcare, LP solely funded the round and now holds a majority ownership position.

Total raised

$3M

Funding rounds

2

Latest round

Equity

Latest activity

Oct 2022